Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

United Health Group Continues To Justify Premium Valuation

Published 10/17/2022, 02:08 AM
Updated 09/29/2021, 03:25 AM
  • UnitedHealth Group is holding onto gains after its positive earnings report.
  • This is happening as the broader market is selling off sharply on inflation concerns.
  • UNH stock trades at a premium to the sector and the market.
  • The data-forward company is attempting to use analytics to improve health outcomes.
  • UnitedHealth Group (NYSE:UNH) stock is up 1.77% in late-day trading after reporting a double beat on third-quarter earnings. The gains would likely be higher but for the broader sell-off taking place in the market.

    At a time when investors are seeking value wherever they can find it, this is something that investors should take note of. However, it’s equally important to point out that United Health Group is trading at a premium to the healthcare sector. It does have the largest market cap in the sector so it may be worth it, and this article will attempt to explain why that may be.

    Business Is Booming

    By any account, this was an exceptional report for United Health Group. Top-line revenue came in at $80.89 billion which was a 12% year-over-year (YOY) increase. The company cited double-digit growth in both its Optum and UnitedHealthcare units.

    On the bottom line, the results were even more impressive. The company posted earnings per share of $5.79, a 28% increase from the prior year.

    And the company’s 6.5% net margin was 16% higher than the prior year and higher than the 6.3% the company posted in the prior quarter.

    All of which is to state the obvious, demand for healthcare continues to grow.

    But if this is just about the growth of healthcare, investors may be able to find some other stocks that have a better valuation. For example, Cigna (NYSE:CI) is also delivering strong year-over-year revenue and earnings growth. But CI stock currently trades at about 17x earnings. UNH stock trades at a hefty 26.9x earnings.

    Know What You Own

    Through its Optum Labs business unit, United Health Group uses “cutting-edge analytic techniques to vast health care data sets.” Optum is attempting to address two key questions which have perplexed the industry for decades:

    • How do you measure effective care based on health outcomes?
    • How do you compensate providers who deliver quality care based on how a patient does in contrast to the traditional fee-for-service model?

    To that end, Optum is seeing growth in what it terms value-based payment arrangements. This means that providers can get paid more based on a how a patient does.

    And to further develop its leadership in the area of data analytics and further grow the area of value-based care, the company looks like a near lock to acquire Change Healthcare (NASDAQ:CHNG). Not only that, but acquisition such as these will help the company lower costs and expand its services.

    UNH Is A Safe Stock To Ride Out This Market

    In a risk-off market, United Health Group is offering growth in a defensive sector. However, for all the good news that United Health Group is delivering, it’s only fair to note that the stock has climbed over 166% in the last five years. It’s fair to wonder how much growth is already factored into the stock price.

    On the other hand, over the last 12 months, UNH stock has still posted a gain of over 22%. But at two different points this year, an area around $247 has acted as firm resistance for the stock.

    Nevertheless, the analysts tracked by MarketBeat give UNH stock a consensus price target of $586.40 which is a 14% gain from the stock’s current level. However, that doesn’t reflect any upcoming upgrades. As of this writing, no analyst had offered an opinion after the company’s earnings report.

    And investors get a compelling dividend that currently pays $6.60 on an annual basis, has a 1.29% yield, and has been growing for the last 12 consecutive years.

    Original Post

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.